Previous 10 | Next 10 |
home / stock / bmymp / bmymp news
Bolt Biotherapeutics has filed proposed terms for a $150 million IPO. The firm is developing antibody conjugate treatments for various cancers. BOLT has produced early efficacy results for its lead program and has an impressive investor syndicate, so the IPO is worth consideration...
I present my 2021 portfolio: 10 stocks that I believe should perform well this year. I explain the rationale behind the picks, esp. the balance between growth, value, speculation, and diversification. The portfolio is up 10% in the first 20 days. Presented are live links for perfo...
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...
Sana Biotechnology has filed to raise $150 million in a U.S. IPO. The firm is a pre-clinical biopharma using cell engineering technologies for an ambitious pipeline of treatment candidates for cancers, liver, and other diseases. SANA is still very early stage and thus high risk bu...
The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event. For further details see: Bristol-Myers Squibb (BMY) Presents At 39th Annual JPMorgan Virtual Healthcare Conference - Slideshow
In 2020, I generated total returns of 24.17%. My dividend income increased by 10.78%, year-over-year. 2020 marked another year of outperformance for me (I've now beaten the S&P 500 during 7 out of the last 9 years). For further details see: Nicholas Ward's Dividend G...
Bristol-Myers Squibb Company (BMY) 39th Annual JPMorgan Virtual Healthcare Conference January 11, 2021, 07:30 AM ET Company Participants Giovanni Caforio - Chairman and Chief Executive Officer Conference Call Participants Chris Schott - JPMorgan Presentation Chris Schott Good morning everybod...
The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event. For further details see: Bristol-Myers-Squibb-JPM-2021-Presentation
2020 was a year of immense adversity and contrast, as stocks bounced back sharply from a pandemic-induced bear market. Biotechs play a pivotal role in managing down the pandemic as vaccine production ramps higher. January to provide further insights on multiple additional vaccine tria...
Monthly update of the Dividend Champions List. 55 companies declared higher dividends in the past month, with an average increase of 6.1% over their previous payouts. One new Champion, ten new Contenders, and seven new Challengers. For further details see: Dividend Champ...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb $2Pr Company Name:
BMYMP Stock Symbol:
OTCMKTS Market:
Bristol-Myers Squibb $2Pr Website: